| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/25/1994 | US5281594 Substituted 1-(alkoxyphenyl)piperazines with ons and antihypertensive activity |
| 01/25/1994 | US5281592 Thiazine derivatives and preparation thereof |
| 01/25/1994 | US5281586 L-α-glycerophosphoryl-D-myo-inositol for the treatment of peripheral neuropathies and of cerebropathies |
| 01/25/1994 | US5281420 Solid dispersion compositions of tebufelone |
| 01/25/1994 | CA2100950A1 Use of competitive nmda receptor antagonists in the treatment of urinary incontinence |
| 01/25/1994 | CA1326485C Thioformamide derivatives |
| 01/25/1994 | CA1326484C Substituted styrene derivatives |
| 01/25/1994 | CA1326483C (aza) naphtalesultame derivatives, processes for their preparation and medicines containing them |
| 01/22/1994 | CA2100944A1 3-(hydroxybenzylidenyl)-indoline-2-ones, their preparation and the pharmaceutical compositions containing them |
| 01/22/1994 | CA2100943A1 Aminoalkylchromones, their preparation and the pharmaceutical compositions containing them |
| 01/22/1994 | CA2100909A1 Method of preparation of physostigmine carbamate derivatives from eseretholes |
| 01/22/1994 | CA2100908A1 Method of preparation of physostigmine carbamate derivatives from physostigmine |
| 01/21/1994 | CA2100830A1 Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions |
| 01/21/1994 | CA2100034A1 Amidines derived from 3-aminoethyl indoles and process for the preparation thereof |
| 01/20/1994 | WO1994001435A1 New analgesic and nootropic drugs |
| 01/20/1994 | WO1994001429A1 (3r,4r)-δ6-tetrahydrocannabinol-7-oic acids |
| 01/20/1994 | WO1994001421A1 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 01/20/1994 | WO1994001099A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| 01/20/1994 | WO1994001095A2 Medicaments for the treatment of visceral pain and migraine |
| 01/20/1994 | WO1994001094A1 Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances |
| 01/20/1994 | CA2139739A1 New analgesic and nootropic drugs |
| 01/20/1994 | CA2139488A1 Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances |
| 01/20/1994 | CA2139440A1 Medicaments for the treatment of visceral pain and migraine |
| 01/20/1994 | CA2139417A1 Benzothiazepine and benzoxazepine derivatives |
| 01/19/1994 | EP0579507A1 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 01/19/1994 | EP0579496A1 4-Aminoquinazoline derivatives, and their use as medicine |
| 01/19/1994 | EP0579263A1 1,4-Substituted piperidines as acetylchozinesterase inhibitors and their use for the treatment of Alzheimer's disease |
| 01/19/1994 | EP0578687A1 Use of deprenyl to maintain, prevent loss, or recover nerve cell function |
| 01/19/1994 | CN1080959A Recombinant stimulating factor of the neu receptor |
| 01/19/1994 | CN1080931A Calcium channel blocking polypeptides from filistata hibernalis |
| 01/19/1994 | CN1080925A Pyrazinoindoles |
| 01/19/1994 | CN1080916A Tachiquinine antagonist tricyclic compounds, preparation of same and pharmaceutical compositions containing such compounds |
| 01/18/1994 | US5280030 Containing 1-benz(oxazole, thiazole or imidazole)-4-imidazole piperidine compound |
| 01/18/1994 | CA2100399A1 Isoxazole derivatives for the treatment of irritable bowel syndrome |
| 01/16/1994 | CA2100626A1 4-aminoquinazoline derivatives |
| 01/13/1994 | DE4222826A1 Arzneimittel zur Verhinderung der Toleranzentwicklung während der Behandlung mit Benzodiazepin-Rezeptor-Bindenen Wirkstoffen Medicines used to prevent the development of tolerance during treatment with benzodiazepine-receptor-binding agents |
| 01/12/1994 | EP0578620A1 Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues |
| 01/12/1994 | EP0578560A2 Amido-alcohol derivatives as psychotropic agents |
| 01/12/1994 | EP0577996A1 Placenta extract and process for preparing it |
| 01/12/1994 | EP0577772A1 Ibuprofen-antitussive combinations |
| 01/12/1994 | EP0577757A1 Ibuprofen-decongestant combinations |
| 01/12/1994 | EP0463101B1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 01/12/1994 | EP0382716B1 Use of commercial lecithin as skin penetration enhancer |
| 01/12/1994 | CN1023485C Substituted silyl alkylene amines |
| 01/12/1994 | CN1023484C 4-(2-pyrimidinyl)-1-piperazinyl heterocylic carbonyl derivatives and the prepn. |
| 01/12/1994 | CN1023480C 3-aryl-5-alkylthio-4h-1,2,4-triazoles derivatives and prepn. method therefor |
| 01/12/1994 | CN1023478C Process for preparing new compound |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5278296 Production of hydroxysteryl glycoside compounds |
| 01/11/1994 | US5278190 Increasing REM stage of sleep and duration of sleep by administering amino acid solution including at least 60% branched-chain amino acids |
| 01/11/1994 | US5278185 Piperidine, Tetrahydropyridine and pyrrolidine compounds |
| 01/11/1994 | US5278174 Sigma binding site agents |
| 01/11/1994 | US5278166 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors |
| 01/11/1994 | US5278164 Treatment of anxiety in benzodiazepine-withdrawn patients |
| 01/11/1994 | US5278162 Learning enhancement |
| 01/11/1994 | US5277907 Regulation of the immune system |
| 01/11/1994 | CA1326033C Pyrrolidineamide derivative having anti-prolyl endopeptidase activity |
| 01/09/1994 | CA2100007A1 Preparation of new amido-alcohol derivatives and their therapeutical applications |
| 01/06/1994 | WO1994000494A1 Improvements in or relating to neuroregeneration |
| 01/06/1994 | WO1994000486A1 Neuropeptide y antagonists |
| 01/06/1994 | WO1994000481A1 Pharmaceutical composition containing botulinum b complex |
| 01/06/1994 | WO1994000458A1 N-substituted 3-azabicyclo[3.2.0]heptane derivates useful as neuroleptic agents, etc. |
| 01/06/1994 | WO1994000441A1 N(hetero)-aryl-n(hetero)-tetralin-alkyl-piperazine having serotoninergic, dopaminergic and adrenergic activity |
| 01/06/1994 | WO1994000440A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/06/1994 | WO1994000434A1 Novel nicotinic acid esters |
| 01/06/1994 | WO1994000431A1 N-substitued 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents etc. |
| 01/06/1994 | WO1994000146A1 Treatment for sensitive teeth |
| 01/06/1994 | WO1994000140A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | WO1994000124A1 Glycine receptor antagonists and the use thereof |
| 01/06/1994 | WO1994000114A1 Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine |
| 01/06/1994 | WO1994000047A1 Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine |
| 01/06/1994 | WO1993016701A3 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 01/06/1994 | WO1992009573A3 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals |
| 01/06/1994 | CA2139136A1 Glial mitogenic factors, their preparation and use |
| 01/06/1994 | CA2139000A1 Methods and compositions for treating depression and other disorders using optically pure(+) sibutramine |
| 01/06/1994 | CA2138998A1 Methods and compositions for treating depression and other disorders using optically pure(-) sibutramine |
| 01/06/1994 | CA2138374A1 Neuropeptide y antagonists |
| 01/06/1994 | CA2137685A1 N(hetero)-aryl-n-(hetero)-tetralin-alkyl-piperazine having serotoninergic, dopaminergic and adrenergic activity |
| 01/05/1994 | EP0577394A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 01/05/1994 | EP0577025A2 Angiotensin-II-receptorantagonist for the treatment and prophylaxis of coronary heart diseases |
| 01/05/1994 | EP0576906A1 Thienothiazine derivatives, process for their preparation and their use as antiinflammatory and analgesic agents |
| 01/05/1994 | EP0576619A1 1,2-dithiole-3-thione derivative-based therapeutical compositions. |
| 01/05/1994 | EP0576611A1 Radiopharmaceutical agents for the detection of alzheimer's disease |
| 01/05/1994 | EP0576603A1 Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen |
| 01/05/1994 | EP0576420A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it. |
| 01/05/1994 | CN1080288A Acylaminoindole derivatives |
| 01/05/1994 | CN1080188A Prevention of retinal injury and degeneration by specific factors |
| 01/05/1994 | CN1023404C Preparation of benzopyran derivatives |
| 01/05/1994 | CN1023402C Preparation of serotonin antagonists |
| 01/05/1994 | CN1023399C Preparation of 8-substituted-2-aminotetralines |
| 01/04/1994 | US5276164 Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide |
| 01/04/1994 | US5276156 N-(halopyridin-4-yl)-N-substituted compounds as intermediates in the preparation of 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl-1H-indoles |
| 01/04/1994 | US5276137 Enkephalin derivatives |
| 01/04/1994 | US5276057 L-deprenyl for treating immune system dysfunction |
| 01/04/1994 | US5276051 Arylethylamine compounds |
| 01/04/1994 | US5276043 Anabasine compounds |
| 01/04/1994 | US5276040 4-(1,2-benzisoxazolyl)piperidine antipsychotic agents |
| 01/04/1994 | US5276036 Central nervous system |
| 01/04/1994 | US5276030 Tranquilizers, antispasmodics, antidepressants |
| 01/04/1994 | US5276027 Ionotropic agents, vasodilation agents, circulation promoters, antiasthmetics, cognition activators, antidepressants and antiinflammatory agents |